Microbix Biosystems Management
Management criteria checks 3/4
Microbix Biosystems' CEO is Cameron Groome, appointed in Jul 2017, has a tenure of 8.58 years. total yearly compensation is CA$552.00K, comprised of 78.3% salary and 21.7% bonuses, including company stock and options. directly owns 2.42% of the company’s shares, worth CA$803.40K. The average tenure of the management team and the board of directors is 9.1 years and 19 years respectively.
Key information
Cameron Groome
Chief executive officer
CA$552.0k
Total compensation
| CEO salary percentage | 78.29% |
| CEO tenure | 8.6yrs |
| CEO ownership | 2.4% |
| Management average tenure | 9.1yrs |
| Board average tenure | 19yrs |
Recent management updates
Recent updates
Is Microbix Biosystems (TSE:MBX) Weighed On By Its Debt Load?
Jan 23
Subdued Growth No Barrier To Microbix Biosystems Inc.'s (TSE:MBX) Price
Nov 21Is Microbix Biosystems (TSE:MBX) A Risky Investment?
Aug 15We Think Microbix Biosystems (TSE:MBX) Can Manage Its Debt With Ease
May 03The Price Is Right For Microbix Biosystems Inc. (TSE:MBX) Even After Diving 26%
Mar 12Microbix Biosystems Inc. (TSE:MBX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Jan 04Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution
Aug 22Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem
Feb 21Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price
Feb 17Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up
Dec 23Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?
Nov 03Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?
Jul 22Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio
May 17Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook
Dec 27Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet
Aug 08Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals
May 20Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly
Feb 06One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates
Dec 28CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2025 | n/a | n/a | -CA$4m |
| Sep 30 2025 | CA$552k | CA$432k | -CA$2m |
| Jun 30 2025 | n/a | n/a | -CA$325k |
| Mar 31 2025 | n/a | n/a | CA$2m |
| Dec 31 2024 | n/a | n/a | CA$2m |
| Sep 30 2024 | CA$660k | CA$420k | CA$4m |
| Jun 30 2024 | n/a | n/a | CA$5m |
| Mar 31 2024 | n/a | n/a | CA$4m |
| Dec 31 2023 | n/a | n/a | CA$4m |
| Sep 30 2023 | CA$477k | CA$406k | -CA$39k |
| Jun 30 2023 | n/a | n/a | -CA$3m |
| Mar 31 2023 | n/a | n/a | -CA$1m |
| Dec 31 2022 | n/a | n/a | -CA$391k |
| Sep 30 2022 | CA$537k | CA$388k | CA$2m |
| Jun 30 2022 | n/a | n/a | CA$3m |
| Mar 31 2022 | n/a | n/a | CA$4m |
| Dec 31 2021 | n/a | n/a | CA$4m |
| Sep 30 2021 | CA$598k | CA$311k | CA$3m |
| Jun 30 2021 | n/a | n/a | -CA$3m |
| Mar 31 2021 | n/a | n/a | -CA$4m |
| Dec 31 2020 | n/a | n/a | -CA$6m |
| Sep 30 2020 | CA$363k | CA$305k | -CA$6m |
| Jun 30 2020 | n/a | n/a | -CA$1m |
| Mar 31 2020 | n/a | n/a | -CA$1m |
| Dec 31 2019 | n/a | n/a | -CA$434k |
| Sep 30 2019 | CA$313k | CA$281k | CA$32k |
Compensation vs Market: Cameron's total compensation ($USD402.83K) is above average for companies of similar size in the Canadian market ($USD154.44K).
Compensation vs Earnings: Cameron's compensation has been consistent with company performance over the past year.
CEO
Cameron Groome
Mr. Cameron L. Groome is Director of Gstaad Capital Corp. He is CEO of Illumisoft Lighting Canada since September 2018. Mr. Groome served as Director of Naegis Pharmaceuticals Inc. He served as an Independ...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 8.6yrs | CA$552.00k | 2.42% CA$ 803.4k | |
| Chief Financial Officer | 9.1yrs | CA$364.88k | 0.22% CA$ 72.0k | |
| Chief Operating Officer | 6.7yrs | CA$366.10k | 0.39% CA$ 129.6k | |
| Senior Vice President of Sales & Business Development | 13.3yrs | CA$332.82k | 0.41% CA$ 137.2k | |
| Senior Vice President of Scientific Affairs | 18.3yrs | CA$316.37k | 0.31% CA$ 102.6k | |
| Compliance Officer | no data | no data | no data |
Experienced Management: MBX's management team is seasoned and experienced (9.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 13.9yrs | CA$552.00k | 2.42% CA$ 803.4k | |
| Independent Director | 23.3yrs | CA$8.00k | 0.40% CA$ 131.8k | |
| Independent Director | 23yrs | no data | 6.9% CA$ 2.3m | |
| Independent Chairman of the Board | 17yrs | CA$17.00k | 1.29% CA$ 430.0k | |
| Independent Director | 20.2yrs | CA$7.00k | 2.16% CA$ 717.5k | |
| Independent Director | 19yrs | CA$16.00k | 1.33% CA$ 442.0k | |
| Independent Director | 3.9yrs | CA$7.00k | 0.019% CA$ 6.3k |
Experienced Board: MBX's board of directors are seasoned and experienced ( 19 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/24 00:23 |
| End of Day Share Price | 2026/02/24 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Microbix Biosystems Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Martin | Bloom Burton & Co. |